10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions.
10x Genomics, Inc.
6230 Stoneridge Mall Road, Pleasanton, CA 94566
CategoryHealth Information Services
10x Genomics’ focus on single-cell genomics technology could contribute to environmental sustainability by advancing research that helps understand diseases and develop targeted treatments. Efficient Operations: The company might focus on energy-efficient laboratory equipment and sustainable practices in its operations.Scientific Advancements: 10x Genomics’ technology supports scientific research, potentially leading to discoveries that improve human health and well-being. Research Collaboration: Collaboration with researchers and institutions positively impacts the broader scientific community.10x Genomics’ commitment to transparency and ethical conduct likely reflects in its corporate governance practices.Revenue Generation: 10x Genomics’ financial sustainability comes from the sale of its genomics solutions and related products. Investor Relations: The company’s ESG efforts can influence investor perception, particularly for those seeking investments aligned with responsible scientific advancements. The company’s ESG initiatives can resonate with investors interested in both financial returns and positive scientific contributions.The company’s technology is likely used in ethical research endeavors to advance human understanding.10x Genomics’ technology contributes to the work of researchers and scientists, positively impacting scientific progress.